High Acceptability of a Vaginal Ring Intended as a Microbicide Delivery Method for HIV Prevention in African Women

被引:75
|
作者
van der Straten, A. [1 ,2 ]
Montgomery, E. T. [1 ]
Cheng, H. [1 ]
Wegner, L. [1 ]
Masenga, G. [3 ]
von Mollendorf, C. [4 ]
Bekker, L. [5 ,6 ]
Ganesh, S. [7 ]
Young, K. [8 ]
Romano, J. [9 ]
Nel, A. [8 ]
Woodsong, C. [8 ]
机构
[1] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA
[2] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA USA
[3] Kiliminjaro Christian Med Ctr, Moshi, Tanzania
[4] Wits Reprod Hlth & HIV Res Inst, Johannesburg, South Africa
[5] Univ Cape Town, ZA-7925 Cape Town, South Africa
[6] Desmond Tutu HIV Fdn, Cape Town, South Africa
[7] S African MRC, Durban, South Africa
[8] Int Partnership Microbicides, Paarl, South Africa
[9] NWJ Grp LLC, Wayne, PA USA
关键词
Vaginal ring; Microbicide; HIV/STI prevention; Acceptability; Africa; INTRAVAGINAL RINGS; CONTRACEPTIVE USE; SAFETY;
D O I
10.1007/s10461-012-0215-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vaginal rings (VRs) are new methods for continuous delivery of microbicides. This is the first study to quantitatively and qualitatively explore the acceptability of rings in Africa: 157 HIV-negative, sexually active women aged 18-35 used a placebo silicone elastomer ring for 12 weeks. They completed product acceptability questionnaires every 4 weeks. We conducted 6 exit focus group discussions with a subset of 48 women and 19 in-depth interviews with male partners. Retention in the study was high (97 %). Initial insertion at the clinic was successful on first attempt for 81 % of participants. Most women were comfortable using the ring, and very few (a parts per thousand currency sign2 %) could feel it during daily activities or had ring-related physical or emotional problems. In the qualitative interviews many participants reported that they initially had concerns about using the ring. However, only a minority of women actually reported concerns with the ring during the study. The most frequent concern was that the ring would get lost inside the body (20 %), and this was significantly correlated with study site, frequently thinking about the ring and reporting that the ring was not very easy to remove. Qualitative data suggest that informants grew to like the ring because it felt securely placed, was unnoticeable during daily activities, and felt "normal" during sex. The ring appeared to be highly acceptable for women and men. Initial concerns with this novel method suggest a need for enhanced product counseling when VRs are introduced.
引用
收藏
页码:1775 / 1786
页数:12
相关论文
共 50 条
  • [31] Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial
    Browne, Erica N.
    Brown, Elizabeth R.
    Palanee-Phillips, Thesla
    Reddy, Krishnaveni
    Naidoo, Logashvari
    Jeenarain, Nitesha
    Nair, Gonasagrie
    Husnik, Marla J.
    Singh, Devika
    Scheckter, Rachel
    Soto-Torres, Lydia
    Baeten, Jared M.
    van der Straten, Ariane
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 (04) : 418 - 424
  • [32] Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex
    Laborde, Nicole D.
    Pleasants, Elizabeth
    Reddy, Krishnaveni
    Atujuna, Millicent
    Nakyanzi, Teopista
    Chitukuta, Miria
    Naidoo, Sarita
    Palanee-Phillips, Thesla
    Baeten, Jared M.
    Montgomery, Elizabeth T.
    AIDS AND BEHAVIOR, 2018, 22 (02) : 437 - 446
  • [33] Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women
    Nel, Annalene M.
    Coplan, Paul
    Smythe, Shanique C.
    McCord, Karen
    Mitchnick, Mark
    Kaptur, Paulina E.
    Romano, Joseph
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (11) : 1181 - 1190
  • [34] Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
    Baeten, J. M.
    Palanee-Phillips, T.
    Brown, E. R.
    Schwartz, K.
    Soto-Torres, L. E.
    Govender, V.
    Mgodi, N. M.
    Kiweewa, F. Matovu
    Nair, G.
    Mhlanga, F.
    Siva, S.
    Bekker, L. -G.
    Jeenarain, N.
    Gaffoor, Z.
    Martinson, F.
    Makanani, B.
    Pather, A.
    Naidoo, L.
    Husnik, M.
    Richardson, B. A.
    Parikh, U. M.
    Mellors, J. W.
    Marzinke, M. A.
    Hendrix, C. W.
    van der Straten, A.
    Ramjee, G.
    Chirenje, Z. M.
    Nakabiito, C.
    Taha, T. E.
    Jones, J.
    Mayo, A.
    Scheckter, R.
    Berthiaume, J.
    Livant, E.
    Jacobson, C.
    Ndase, P.
    White, R.
    Patterson, K.
    Germuga, D.
    Galaska, B.
    Bunge, K.
    Singh, D.
    Szydlo, D. W.
    Montgomery, E. T.
    Mensch, B. S.
    Torjesen, K.
    Grossman, C. I.
    Chakhtoura, N.
    Nel, A.
    Rosenberg, Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2121 - 2132
  • [35] UPDATE ON MICROBICIDE RESEARCH AND DEVELOPMENT - SEEKING NEW HIV PREVENTION TOOLS FOR WOMEN
    Mertenskoetter, T.
    Kaptur, P. E.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (01) : 1 - 6
  • [36] Acceptability, tolerability, and satisfaction of a contraceptive vaginal ring (the NuvaRing) among Thai women
    Santibenchakul, Somsook
    Jaisamrarn, Unnop
    ASIAN BIOMEDICINE, 2016, 10 (03) : 235 - 241
  • [37] Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States
    Elizabeth T. Montgomery
    Lisa M. Noguchi
    James Y. Dai
    Jason Pan
    Joseph Biggio
    Craig Hendrix
    Karen Isaacs
    D. Heather Watts
    Jill L. Schwartz
    Jeanna Piper
    Richard Beigi
    AIDS and Behavior, 2018, 22 : 402 - 411
  • [38] Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls
    Baker, Zoe
    Javanbakht, Marjan
    Moore, Janell
    Brosnan, Hannah
    Squires, Kathleen
    Bunge, Katherine
    Zimet, Gregory
    Mensch, Barbara
    Soto-Torres, Lydia
    Kapogiannis, Bill
    Levy, Lisa
    Hoesley, Craig
    Reirden, Daniel
    Gaur, Aditya
    Mayer, Kenneth
    Futterman, Donna
    Gorbach, Pamina
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 87 (03) : 944 - 950
  • [39] A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women
    Nel, Annalene
    Haazen, Wouter
    Nuttall, Jeremy
    Romano, Joseph
    Rosenberg, Zeda
    van Niekerk, Neliette
    AIDS, 2014, 28 (10) : 1479 - 1487
  • [40] Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV Prevention
    Tiantian Gong
    Wei Zhang
    Michael A. Parniak
    Phillip W. Graebing
    Bernard Moncla
    Phalguni Gupta
    Kerry M. Empey
    Lisa C. Rohan
    Journal of Pharmaceutical Innovation, 2017, 12 : 142 - 154